Biological Activities of Lasso Peptides and Structure–Activity Relationships - Lasso Peptides: Bacterial Strategies to Make and Maintain Bioactive Entangled Scaffolds - page 71

Locher KP, Rees B, Koebnik R, Mitschler A, Moulinier L, Rosenbusch JP, Moras D (1998) Trans-
membrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferri-
chrome-bound states reveal allosteric changes. Cell 95(6):771-778
Lopez FE, Vincent PA, Zenoff AM, Salomon RA, Farias RN (2007) Efficacy of microcin J25
in biomatrices and in a mouse model of Salmonella infection. J Antimicrob Chemother
59(4):676-680. doi:10.1093/jac/dkm009
López A, Tarragó T, Giralt E (2011) Low molecular weight inhibitors of Prolyl Oligopeptidase: a
review of compounds patented from 2003 to 2010. Expert Opin Ther Pat 21(7):1023-1044. do
i:10.1517/13543776.2011.577416
Lukas TJ, Mirzoeva S, Slomczynska U, Watterson DM (1999) Identification of novel classes of
protein kinase inhibitors using combinatorial peptide chemistry based on functional genomics
knowledge. J Med Chem 42(5):910-919. doi:10.1021/jm980573a
Ma P, Nishiguchi K, Yuille HM, Davis LM, Nakayama J, Phillips-Jones MK (2011) Anti-HIV
siamycin I directly inhibits autophosphorylation activity of the bacterial FsrC quorum sen-
sor and other ATP-dependent enzyme activities. FEBS Lett 585(17):2660-2664. doi:10.1016/j.
febslet.2011.07.026
Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA
(1987) Physiological role of silent receptors of atrial natriuretic factor. Science 238(4827):675-
678
Madsen P, Knudsen LB, Wiberg FC, Carr RD (1998) Discovery and structure-activity relation-
ship of the first non-peptide competitive human glucagon receptor antagonists. J Med Chem
41(26):5150-5157. doi:10.1021/jm9810304
Maeda M, Mizuno Y, Wakita M, Yamaga T, Nonaka K, Shin MC, Shoudai K, Akaike N (2013)
Potent and direct presynaptic modulation of glycinergic transmission in rat spinal neurons by
atrial natriuretic peptide. Brain Res Bull 99:19-26. doi:10.1016/j.brainresbull.2013.09.003
Maes M, Goossens F, Scharpe S, Meltzer HY, D'Hondt P, Cosyns P (1994) Lower serum prolyl
endopeptidase enzyme activity in major depression: further evidence that peptidases play a role
in the pathophysiology of depression. Biol Psychiatry 35(8):545-552
Maes M, Goossens F, Scharpe S, Calabrese J, Desnyder R, Meltzer HY (1995) Alterations in
plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of anti-
depressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res 58(3):217-225
Maksimov MO, Pelczer I, Link AJ (2012) Precursor-centric genome-mining approach for lasso
peptide discovery. Proc Natl Acad Sci U S A. doi:10.1073/pnas.1208978109
Männistö PT, Venalainen J, Jalkanen A, Garcia-Horsman JA (2007) Prolyl oligopeptidase: a po-
tential target for the treatment of cognitive disorders. Drug News Perspect 20(5):293-305.
doi:10.1358/dnp.2007.20.5.1120216
Mantle D, Falkous G, Ishiura S, Blanchard PJ, Perry EK (1996) Comparison of proline endopepti-
dase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body
dementia, Parkinson's disease and Huntington's disease. Clin Chim Acta 249(1-2):129-139
Mariani R, Maffioli SI (2009) Bacterial RNA polymerase inhibitors: an organized overview of
their structure, derivatives, biological activity and current clinical development status. Curr
Med Chem 16(4):430-454
Masaki T (2004) Historical review: Endothelin. Trends Pharmacol Sci 25(4):219-224.
doi:10.1016/j.tips.2004.02.008
Mathavan I, Zirah S, Mehmood S, Choudhury HG, Goulard C, Li Y, Robinson CV, Rebuffat S,
Beis K (2014) Structural basis for hijacking outer membrane siderophore receptors by antimi-
crobial peptides: structure of the lasso peptide microcin J25 bound to FhuA. Nat Chem Biol
10(5):340-342
Mattiuzzo M, Bandiera A, Gennaro R, Benincasa M, Pacor S, Antcheva N, Scocchi M (2007)
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. Mol
Microbiol 66(1):151-163. doi:10.1111/j.1365-2958.2007.05903.x
Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, Drucker DJ (2003) International
Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55(1):167-
194. doi:10.1124/pr.55.1.6